For: | Wu Y, Yin AH, Sun JT, Xu WH, Zhang CQ. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells. World J Gastroenterol 2023; 29(33): 4975-4990 [PMID: 37732000 DOI: 10.3748/wjg.v29.i33.4975] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v29/i33/4975.htm |
Number | Citing Articles |
1 |
Qiaohui Shen, Ming Yang, Song Wang, Xingyu Chen, Sulan Chen, Rui Zhang, Zhuang Xiong, Yan Leng. The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1374644
|
2 |
Youtian Zhang, Long Ren, Yinting Tian, Xiaohu Guo, Fengxian Wei, Yawu Zhang. Signaling pathways that activate hepatic stellate cells during liver fibrosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1454980
|
3 |
Michele Barone. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?. World Journal of Gastroenterology 2024; 30(18): 2391-2396 doi: 10.3748/wjg.v30.i18.2391
|
4 |
Bingge Fan, Lingbing Meng, Xiao Zheng, Lei Bai, Yaping Du, Haiyan Ding, Yu Chen, Yuna Zhang. Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-97872-w
|
5 |
Bai-Wei Zhao, Ying-Jia Chen, Ruo-Peng Zhang, Yong-Ming Chen, Bo-Wen Huang. Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system. World Journal of Gastroenterology 2024; 30(6): 607-609 doi: 10.3748/wjg.v30.i6.607
Abstract(523) |
Core Tip(573) |
Full Article(HTML)(1616)
|
Full Article with Cover (PDF)-603K(164)
|
Full Article (Word)-114K(23)
|
Audio-8440K(6)
|
Peer-Review Report-217K(74)
|
Answering Reviewers-109K(66)
|
Full Article (PDF)-344K(148)
|
Full Article (XML)-38K(77)
|
Times Cited (3)
|
Total Visits (4345)
|
Open
|